Loading stock data…
Cumberland Pharmaceuticals Inc. (CPIX)
$6.61-0.38 (-5.37%)
Market ClosedLast close Jul 24
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cumberland Pharmaceuticals Inc. in the Healthcare sector is trading at $6.61 with a market capitalization of $84M. The stock is currently 18% below its 52-week high of $8.09, remaining 60.0% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.13M↓ | $13.68M↑ | $8.29M↓ | $10.84M↓ | $11.71M |
| Gross Profit | $7.20M↓ | $11.44M↑ | $7.30M↓ | $8.83M↓ | $10.29M |
| Operating Income | -$3.13M↓ | -$1.37M↑ | -$1.97M↓ | -$747,478↓ | $1.29M |
| Net Income | -$3.29M↓ | -$1.41M↑ | -$1.94M↓ | -$740,740↓ | $1.26M |
Peer Comparison
JNJUNHPFE
Fundamentals
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Cal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$84.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-34.12%
Volume
Today's trading volume
123,332
Recent News
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?
Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks were higher late Friday afternoon, with the NYSE Healthcare Index rising 2.2% and
Sector Update: Healthcare Stocks Gain Friday Afternoon
Healthcare stocks were higher Friday afternoon, with the NYSE Healthcare Index rising 2.3% and the S
Cumberland Expands Global Reach With Vibativ Launch in China
CPIX launches Vibativ in China through SciClone, expanding access to its antibiotic treatment for serious Gram-positive bacterial infections.
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial
Alphabet, Apple and Micron lead Zacks analyst reports as AI demand and product cycles drive tech momentum.